PD-1/PD-L1 Pathway and Its Blockade in Patients with Classic Hodgkin Lymphoma and Non-Hodgkin Large-Cell Lymphomas

被引：0
|
作者：
Wei Xie
L. Jeffrey Medeiros
Shaoying Li
C. Cameron Yin
Joseph D. Khoury
Jie Xu
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Hematopathology
[2] Baylor College of Medicine,Department of Pathology & Immunology
来源：
Current Hematologic Malignancy Reports | 2020年 / 15卷
关键词：
PD-1; PD-L1; Lymphoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：372 / 381
页数：9
相关论文
共 50 条
  • [41] Development of cancer immunotherapy based on PD-1/PD-L1 pathway blockade
    Zhang, Min
    Liu, Kehai
    Wang, Mingfu
    RSC ADVANCES, 2019, 9 (58) : 33903 - 33911
  • [42] Targeting the PD-1 pathway in patients with relapsed classic Hodgkin lymphoma following allogeneic stem cell transplant is safe and effective
    Villasboas, Jose Caetano
    Ansell, Stephen M.
    Witzig, Thomas E.
    ONCOTARGET, 2016, 7 (11) : 13260 - 13264
  • [43] Toxicities Associated With PD-1/PD-L1 Blockade
    Wang, Daniel Y.
    Johnson, Douglas B.
    Davis, Elizabeth J.
    CANCER JOURNAL, 2018, 24 (01): : 36 - 40
  • [44] Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy
    Kirienko, Margarita
    Sollini, Martina
    Chiti, Arturo
    CLINICAL AND TRANSLATIONAL IMAGING, 2018, 6 (06) : 417 - 427
  • [45] PD-1 and PD-L1 blockade in gastrointestinal malignancies
    Lote, Hazel
    Cafferkey, Catherine
    Chau, Ian
    CANCER TREATMENT REVIEWS, 2015, 41 (10) : 893 - 903
  • [46] Mechanisms of Resistance to PD-1 and PD-L1 Blockade
    Nowicki, Theodore S.
    Hu-Lieskovan, Siwen
    Ribas, Antoni
    CANCER JOURNAL, 2018, 24 (01): : 47 - 53
  • [47] Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy
    Margarita Kirienko
    Martina Sollini
    Arturo Chiti
    Clinical and Translational Imaging, 2018, 6 : 417 - 427
  • [48] Efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors in treating non-Hodgkin lymphoma: A systematic review and meta-analysis of clinical trials
    Guan, Jiaheng
    Zhang, Jing
    Zhang, Xiaoping
    Yuan, Zhongshu
    Cheng, Jian
    Chen, Baoan
    MEDICINE, 2022, 101 (50)
  • [49] Implementing PD-1 antibodies in the treatment of patients with Hodgkin lymphoma
    Engert, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 227 - 228
  • [50] Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade
    Lin, Heng
    Wei, Shuang
    Vatan, Linda
    Kryczek, Ilona
    Zou, Weiping
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
12345